Osteoarthritis, the most common form of arthritis, is primarily caused by wear and tear on the protective layer of cartilage ...

A recent study found semaglutide – the drug known as Ozempic – can improve knee pain in people with obesity and ...

Long acting injection Fluticasone promising in knee osteoarthritis suggests a new study published in the The Lancet ...

Enlivex (ENLV) has released an update. Enlivex Therapeutics has commenced the next phase of its Allocetra trial, enrolling and dosing the first ...

A new study shows that Ozempic may help ease arthritis knee pain in people with obesity. Here's what to know about the study and whether semaglutide can truly help reduce knee pain, according to ...

“There are genetic aspects, physical aspects, and inflammatory aspects,” he says. Ozempic can help people to lose weight, ...

“Among participants with obesity and knee osteoarthritis with moderate-to-severe pain, treatment with once-weekly injectable ...

Knee osteoarthritis treatments are challenging due to pain and joint structure variability. Lorecivivint (LOR) is an ...

Topline results were announced from a phase 3 clinical trial evaluating subcutaneous semaglutide in obesity and knee osteoarthritis.

Organogenesis (ORGO) announced the favorable outcome of the interim analysis of its second Phase 3 randomized control trial of ReNu, a ...